TY - JOUR
T1 - A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis
AU - Weinshenker, B. G.
AU - Penman, M.
AU - Bass, B.
AU - Ebers, G. C.
AU - Rice, G. P.A.
PY - 1992/8
Y1 - 1992/8
N2 - Fatigue occurs in a majority of patients with MS and is generally independent of measurable neurologic disability. Few options for treatment are available. We conducted a double–blind, placebo–controlled, crossover trial for each of two 4–week treatment periods. Forty–six eligible patients entered and five dropped out due to concurrent exacerbations. Nineteen patients (46.3%) experienced excellent or good relief of fatigue with pemoline, and eight patients (19.5%) with placebo (p = 0.06, Fisher's exact test). One–fourth of patients did not tolerate the drug well, and 7% had to discontinue pemoline during the study due to side effects. The most common side effects were anorexia, irritability, and insomnia. Pemoline may be an effective short–term treatment for fatigue associated with MS, but its adverse effects are not well tolerated by many patients.
AB - Fatigue occurs in a majority of patients with MS and is generally independent of measurable neurologic disability. Few options for treatment are available. We conducted a double–blind, placebo–controlled, crossover trial for each of two 4–week treatment periods. Forty–six eligible patients entered and five dropped out due to concurrent exacerbations. Nineteen patients (46.3%) experienced excellent or good relief of fatigue with pemoline, and eight patients (19.5%) with placebo (p = 0.06, Fisher's exact test). One–fourth of patients did not tolerate the drug well, and 7% had to discontinue pemoline during the study due to side effects. The most common side effects were anorexia, irritability, and insomnia. Pemoline may be an effective short–term treatment for fatigue associated with MS, but its adverse effects are not well tolerated by many patients.
UR - http://www.scopus.com/inward/record.url?scp=0026666384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026666384&partnerID=8YFLogxK
U2 - 10.1212/wnl.42.8.1468
DO - 10.1212/wnl.42.8.1468
M3 - Article
C2 - 1641137
AN - SCOPUS:0026666384
SN - 0028-3878
VL - 42
SP - 1468
EP - 1471
JO - Neurology
JF - Neurology
IS - 8
ER -